Press releases

RaySearch releases RayCare 2023B

RaySearch Laboratories AB (publ) announces the release of the latest version of RayCare®*, the next generation oncology information system. RayCare® 2023B* features a deeper and richer integration between RaySearch’s products than ever before and introduces support for specification of the radiotherapy treatment course in RayCare, improving usability and efficiency of treatment management.

A key feature of RayCare 2023B is the enhanced fully integrated management of radiotherapy treatment courses from prescription to the review of treatment results in RayCare. A new dedicated workspace for treatment course management supports all user needs in relation to managing the fractionation schedule for treatments including assignment of plans, managing treatment settings and handling approvals. Combined with the digital workflow support and treatment scheduling capabilities in RayCare as well as the integration with RayStation, treatment management is made simpler and more efficient.

RayCare 2023B features a deeper and richer integration than ever before between RaySearch’s products, supporting more automated data transfer and a more cohesive user experience throughout the radiotherapy flow. The enhanced design supports efficiency and safety in the clinical workflow by reducing the number of manual actions and having structured data readily available where needed at all steps.

Other feature updates in this version include enhanced treatment schedules, support for more data migration as well as feature and usability updates to the patient chart and task management. 

Johan Löf, founder and CEO, RaySearch, says: “It is satisfying to see the increased interest for RayCare as well as more clinics using the products in their clinical routine. We continue to further develop the product at a high pace and this release marks an even more integrated solution with the rest of our products to provide an efficient and superior user experience.”

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.  

RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at

About RayCare
The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future. 

* Subject to regulatory clearance in some markets.

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00